Sign up to our newsletter Subscribe
Establishing the Economic Value of Carbon-Minimal Inhalers

Sign up to our newsletter Subscribe
Paul joined the OHE in August 2024 as Graduate Economist. Before joining us, Paul had previously worked on various research projects focusing on improving patient access to cancer therapies in Low- and Middle-income countries.
Paul holds an MSc in Health Economics and Decision Modelling from the University of Sheffield and has previously completed a Post-Graduate Certificate in Global Health and Epidemiology from the University of Dundee. For his master’s dissertation, he carried out an empirical de-novo cost-effective analysis for the treatment of the rare adult-onset dermatomyositis in UK population. Paul’s research interests are in cost effectiveness modelling, the economic evaluation of rare diseases, and pricing strategies for innovative therapies.
An error has occurred, please try again later.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!